A Study to Assess Growth in Children With Idiopathic Short Stature
← catalyst calendarNCT06309979 · readout in 5,248 d
Sponsored by BioMarin Pharmaceutical (industry) · BMRN — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
300estimated
Sites
38
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-08-08 | actual | When the study began enrolling |
| Primary completion | 2040-12-31 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2040-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2024-03-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-06-23 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Idiopathic Short Stature
Primary outcomes
what the primary-completion date above is the date OFChange in annualized growth velocity (AGV)
measured Every 6 months through end of study, up to 15 years
Change in Height Z-score
measured Every 6 months through end of study, up to 15 years
Change in Standing Height
measured Every 6 months through end of study, up to 15 years
Change in BMI
measured Every 6 months through end of study, up to 15 years
Change in BMI Z-score
measured Every 6 months through end of study, up to 15 years
Permalink · BMRN's whole pipeline · Catalyst calendar · Every registered study · What changed